Pharmaceutical technology and Swiss Alipheron jointly launched a large-scale compound library to help drug discovery.

According to the news from Drug Stone Technology, recently, Drug Stone Technology and the Swiss chemical informatics company Alipheron announced a strategic partnership. By integrating Drug Stone Technology's unique resource advantages in molecular building blocks with Alipheron's leading chemical informatics platform tools, the two parties have successfully constructed a super-large compound library containing over 570 billion new compounds. This breakthrough will significantly improve the efficiency of drug discovery and provide global researchers with immediate access to chemical space exploration solutions.